ReviewFrontiers in immunology2019

CAR-Engineered NK Cells for the Treatment of Glioblastoma: Turning Innate Effectors Into Precision Tools for Cancer Immunotherapy.

Michael C Burger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.